Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma <it>in situ</it>
<p>Abstract</p> <p>Background</p> <p>Endocrine therapy is commonly recommended in the adjuvant setting for patients as treatment for ductal carcinoma <it>in situ </it>(DCIS). However, it is unknown whether a neoadjuvant (preoperative) anti-estrogen approach...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-08-01
|
| Series: | BMC Cancer |
| Online Access: | http://www.biomedcentral.com/1471-2407/9/285 |